New House bill aims to shore up US API production in response to pandemic shortages
Amidst heavy demand for drugs and vaccines throughout the world, a new House bill, dubbed the PREPARE ACT of 2021, would create a national stockpile of active pharmaceutical ingredients and prevent supply chain shortages.
The bill, introduced by Reps. Abigail Spanberger (D-VA), and David McKinley (R-WV), would ensure the country has a stockpile of APIs needed to manufacture generics for a list of essential medicines that would be determined by a group that includes the FDA commissioner, the assistant secretary for preparedness and response and the secretary of defense. The FDA commissioner has already identified a list as of Oct. 30, which would be updated at least once a year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.